Randomized phase II trial of intravenous RO5137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 4102-4102 ◽  
Author(s):  
Chia-Jui Yen ◽  
Bruno Daniele ◽  
Masatoshi Kudo ◽  
Philippe Merle ◽  
Joong-Won Park ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Randomized Phase Ii ◽  
Previously Treated Patients ◽  
Previously Treated

Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 4076-4076 ◽  
Author(s):  
Masafumi Ikeda ◽  
Satoshi Shimizu ◽  
Tosiya Sato ◽  
Manabu Morimoto ◽  
Yoshitaka Inaba ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Randomized Phase Ii

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

2011 ◽  
Vol 69 (3) ◽  
pp. 773-780 ◽  
Author(s):  
Iacopo Petrini ◽  
Monica Lencioni ◽  
Miriam Ricasoli ◽  
Mauro Iannopollo ◽  
Cinzia Orlandini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer

2007 ◽  
Vol 61 (3) ◽  
pp. 503-508 ◽  
Author(s):  
Fumiyoshi Ohyanagi ◽  
Atsushi Horiike ◽  
Yoshio Okano ◽  
Yukitoshi Satoh ◽  
Sakae Okumura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document